POMPANO BEACH, Fla., April 08, 2025 (GLOBE NEWSWIRE) — BioStem Technologies Inc. BSEM, a number one MedTech firm centered on the event, manufacture, and commercialization of placental-derived biologics for superior wound care, publicizes that it’ll launch its fourth quarter and full yr 2024 monetary outcomes on Monday, April 14, 2025, and host a convention name and webcast at 4:30 PM ET.
The webcast will characteristic an summary of the quarter from Jason Matuszewski, CEO, and Michael Fortunato, CFO. To register for the occasion, please click on HERE.
Convention Name & Webcast Data:
Be part of BioStem’s Distribution Record & Social Media:
To comply with the newest developments at BioStem, sign-up to the Firm’s e-mail distribution checklist HERE, and comply with us on X and LinkedIn.
About BioStem Applied sciences, Inc. BSEM: BioStem Applied sciences is a number one innovator centered on harnessing the pure properties of perinatal tissue within the growth, manufacture, and commercialization of allografts for regenerative therapies. The Firm is concentrated on manufacturing merchandise that change lives, leveraging its proprietary BioREtain® processing technique. BioREtain® has been developed by making use of the newest analysis in regenerative medication, centered on sustaining development elements and preserving tissue construction. BioStem Applied sciences’ high quality administration system and commonplace working procedures have been reviewed and accredited by the American Affiliation of Tissue Banks (“AATB”). These methods and procedures are established per present Good Tissue Practices (“cGTP”) and present Good Manufacturing Processes (“cGMP”). Our portfolio of high quality manufacturers contains AmnioWrap2™, VENDAJE®, VENDAJE AC®, and VENDAJE OPTIC®. Every BioStem Applied sciences placental allograft is processed on the Firm’s FDA registered and AATB accredited website in Pompano Seaside, Florida. For extra info go to biostemtechnologies.com and comply with us on Twitter and Linkedin.
Ahead-Wanting Statements: Aside from statements of historic truth, this launch additionally incorporates forward-looking statements throughout the which means of the Personal Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts of future occasions. Ahead-looking statements could also be recognized utilizing phrases akin to “forecast,” “intend,” “search,” “goal,” “anticipate,” “consider,” “anticipate,” “estimate”, “plan,” “outlook,” and “venture” and different related expressions that predict or point out future occasions or developments or that aren’t statements of historic issues. Ahead-looking statements with respect to the operations of the Firm, methods, prospects and different facets of the enterprise of the Firm are based mostly on present expectations which might be topic to identified and unknown dangers and uncertainties, which might trigger precise outcomes or outcomes to vary materially from expectations expressed or implied by such forward-looking statements. These elements embody, however will not be restricted to: (1) the impression of any modifications to the reimbursement ranges for the Firm’s merchandise; (2) the Firm faces vital and persevering with competitors, which might adversely have an effect on its enterprise, outcomes of operations and monetary situation; (3) speedy technological change might trigger the Firm’s merchandise to change into out of date and if the Firm doesn’t improve its product choices by its analysis and growth efforts, it could be unable to successfully compete;(4) to be commercially profitable, the Firm should persuade physicians that its merchandise are protected and efficient alternate options to current remedies and that its merchandise needs to be used of their procedures; (5) the Firm’s means to boost funds to broaden its enterprise; (6) the Firm has incurred vital losses since inception and should incur losses sooner or later; (7) modifications in relevant legal guidelines or rules; (8) the chance that the Firm could also be adversely affected by different financial, enterprise, and/or aggressive elements; (9) the Firm’s means to take care of manufacturing of its merchandise in ample portions to fulfill demand; and (10) the COVID-19 pandemic and its impression, if any, on the Firm’s fiscal situation and outcomes of operations; You’re cautioned to not place undue reliance upon any forward-looking statements, which converse solely as of the date made. Though it could voluntarily achieve this once in a while, the Firm undertakes no dedication to replace or revise the forward-looking statements, whether or not because of new info, future occasions or in any other case, besides as required by relevant securities legal guidelines.
BioStem Applied sciences, Inc.
Cellphone: 954-380-8342
Web site: http://www.biostemtechnologies.com
E-Mail: [email protected]
Twitter: @BSEM_Tech
Fb: BioStemTechnologies
PCG Advisory
Adam Holdsworth
E-Mail: [email protected]
Cellphone: 917-497-9287
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
